|
WO03041710A1
|
|
Methods for preventing or treating disease mediateb by toxin-secreting bacteria
|
|
EP1299411A1
|
|
Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
|
|
CA2403292A1
|
|
Microbial delivery system
|
|
WO0139800A2
|
|
Controlled delivery of antigens
|
|
WO0140264A2
|
|
Peptide antigens
|
|
AU3933500A
|
|
Methods for skewing the balance between th1 and th2 immune responses
|
|
AU3760100A
|
|
Immunostimulatory nucleic acids and antigens
|
|
AU2877500A
|
|
Method for altering undesirable immune responses to polypeptides
|
|
CA2357413A1
|
|
Sensitizing agents for the treatment of skin lesions
|
|
US6299875B1
|
|
Methods to block IGE binding to cell surface receptors of mast cells
|
